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$omalostcttln 14 (SS 14] ~as ~en isolated from pancreatic extracts, bLtt open |el filtration immunoreactiw $$ often elutes in two peaks, We isolaled 
both i~aks, but upon ~quetw¢ analysis only authentic SS 14 ¢onld ~ id©ntilled, ['iF f0rth~r |el filtration ~:xpcrlments i  turned out that both slcnthet- 
i¢ and extra,table $$ ap~ared homogeneous at neutral pH ?.~, hut showed Iii! additional, earlier peak in acetic acid. Af|¢r additio~ of mereaptoeth. 
anal, all of the $5 ¢hlted at this earlier position rellardless orthe pH, We= conclude that partial reduction/oxidation fS$ es plains the heterogeneity, 
Pancreatic somatostatin; ProsomatoSlatin pr~essinil: DesA|al-~omatos|atirt; Pancreatic slet 
1. INTRODUCTION 
The somatostatin gene [1] is expressed in numerous 
cells o f  the body [2], including the D-cells of the pan- 
creatic islets [31, Prosomatostatin (preSS), the primary 
translation product is, however, subjected to differen- 
tial processing in the different issues i,a whicl~ it is pro. 
duced. In the endocrine cells of the small intestinal 
mucosa, the C-terminal part of preSS is cleaved to give 
rise to somatostatin 28 (corresponding to preSS 65-92), 
whereas in the pancreas this sequence of preSS gives 
rise to somatostatin 14 (corresponding to preSS 79-92) 
and the 1-12 fragment of somatostatin 28 (correspon- 
ding to preSS 65-'/6) [4-6]. 
In many studies pancreatic somatostatin, however, 
shows some heterogeneity. The heterogeneity appears 
by size fractionation (gel filtration) of pancreatic ex- 
tracts, whereby somatostatin-like immunoreactivity 
(SLI) typically elutes in a double-peaked pattern around 
the position of synthetic somatostatin [6-10]. The two 
peaks have been interpreted to indicate the presence of 
two immunoreactive molecular forms with a slight dif- 
ference in size. In the circulation, somatostatin 14 is 
very rapidly degraded to desAlat-somatostatin 14
[11-13] and these two molecular forms, when mixed 
together, elute by gel filtration in a similar double. 
peaked pattern. It was therefore speculated [6,7,10] 
that the molecular heterogeneity in pmxcreatic extracts 
could be due to the presence of approximately equal 
amounts of somatostatin 14 and desAlat-somatostatin. 
The present study was undertaken to elucidate the 
chemical structures responsible for the heterogeneity. 
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2. MATERIALS  AND METHODS 
Pancreatic tissue was obtained from anaeslhelic~:ed pills and Ira. 
mediately frozen in dry.Ice, The froxen tissue was crushed and 
homotteni zed in ice.cold acid.ethanol nnd further processed according 
to method It In (10J. In short, lheacid,ethanol extract was mixed with 
S vols of i<e-cold diethyl ether, The aqueous phase, containing the ex. 
tractcd proleins and pep~ides, was collected at -50"C and 
reconstituted in distilled water containing in addition 2 mol/I urea 
(analytical 8rade), This merited was chosen because among so, era1 
tested it gave the highest yield of somatostatin [10], After removal of 
a small sample for citromatographic analysis tile extract was applied 
to a 3 × lS ¢m glass column packed with Techoprep C.I8, 40-63 ~m 
(HPLC Technology, Macclesfield, Cheshire, UK) and eluttd with a 
gradient of 20-80°70 ethanol in water containing, in additior, 0.1070 
trlfluoroacetic acid (Merck, Darn'~stadt, Germany), All fractions con. 
taining sol'natostatln.lik¢ immunoreactivity were pooled and sub. 
jccted to gel fihratlon on a 50 x 10~0 mm borosilicate glass column 
(K 50/1000, Pharm.qcia Fine Chemicals Uppsala, Sweden) packed 
with $ephadex O50 SF, which was equilib rated and eluted at 40C with 
0.5 M acetic acid at a flow rate of 60 ml/h. Further chromatographic 
analysi~ was performed on 16 x 1000 mm columns (K 16/tO0, Phar. 
matin) packed with Sephadex GSO F (Pharmacla) nd eluted at a flow 
rate of 20 ml/h at 4°C, using as ¢luants either 0,5 mol/l acetic acid as 
aoovc or the radioimmunoassay buffer: 0,05 mol/l sodium 
phospl'mt¢, pH 7.5, containing in addition 0,1% human serum 
albumh (Reinst, Trocken, Behrringwcrke, Marburg/Lahn, Ger- 
many), O,t mol/l NaCl, and 0,6 mol/l thiomersal, ~'~l-Iabelled 
albumin and 2'NaCl in trace amounts were added to all samples ap. 
plied t~ gel filtration as internal markers. Elution positions are refer- 
red to by tim coefficient of distribution, Kd = eve- Vo)/(Vi- Vo), 
where V= is the elution volume of the substance in question, Vo the 
¢lution volume of l'Sl-albumin and V~ that of 2=Na. 
HPLC analysis was performed using a 4 ×250 mm column of 
Nucleostl Cts ~00, 10/am (Macheray-Nagel, Duren, Germany) eluted 
with mixtures of distilled water containing 0.1070 of trifluoroacetic 
acid (Pierce Chemical Co,, Rockford, IL, USA) (phase A) and 
acetonitrile (Grade S, Rathburn Chemicals Ltd, Walkerburn, UK), 
80°70 (v/v) in distilled water containing 0.1°70 TFA (phase B). 
~equence analysis was performed Usirtg an. automatic protein se- 
quencer (Model 475A, Applied Biosystems) equipped with on-line 
HPLC detection of the PTH.derivatives. To improve the separation 
of Trp from the sequencer byproduct, N,N'-diphenylurea,  
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modiflouton of  Ih¢ lir,'ldl¢ni (RIJN 41t0.L] recommended by ^pplt id 
itlosyslerltti will employid, Cy~t¢In~ restdii¢'~ were not dir lv l i l i t ld,  so 
Ih ly  wlrt  not dile¢lid, 
Radiolmmuncas~y for somitits~ililin.llk¢ tmm~tnoi'tavl|vhy wal 
perrormed ii.t di~eriltttl In detail in [14l .t lt l l i  ari l it ir itm I I : t l ,  raised 
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3. RESULTS 
Fig. IA shows the elution profile of  immunoreactive 
somatostatin in the extract prepared from porcine pan- 
creas, a sample of which was applied to a Sephadex (350 
F column and eluted with acetic acid. The $LI appeared 
as a broad double peak with il',~ values around l.O, The 
extract was concentrated by chromatograpl~y on Techo. 
prep Ct= (Fig. IB), from which the SLI eluted as a nar- 
row peak. Upon r¢chromatollraphy on Sephadex GS0 
(acetic acid) the double peak profile was retained (not 
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Fig, !. Purification of porcine pancreatic somatostatin. Panel A 
shows the gel Filtration profi • of SLI in an acid.ethanol extract of  
pancreas applied directly to a Sephadex G50 column eluted with acetic 
acid. The effluent SLI concentration is plotted against coefficient of 
distribution, Nd, Panel B shows the SLI eluted from a Techoprep col. 
umn with a gradient of ethanol as indicated by the dotted line. Ef- 
fluent SLI concentration is plotted against retention time. Panel C 
shows the optical density, monitored continuously at 225 am, of the 
final HPLC run of a pancreatic extract, The HPLC column was 
eluted with a gradient of acetonitrile as indicated by the dotted line. 
All of the SLI coeluted with the homogenous peak with a retention 
time of 36 men (not shown). Panel D shows the SLI elutton profile of 
synthetic cyclic somatostatln, dissolved in acetic acid and subjected to 
gel filtration in acetic acid. 
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~hown), The lmm~nore=i¢iive fritetlons were pooled, 
and htilf of the material was applied to the FIPLC col. 
.ran and eluled with a linear llritdlinl of acelonitrll¢ 
(0-100% B in I05 miri); The Imrnunoreactiv¢ materlal, 
which ehlled as a sinlle homotenolit peak, was pooled 
and reehromlilotraphed twice, From the list nm a 
sinlll¢, immiinoreaclive peak ¢luled which also lip. 
peitred homollenoas by UV absorption (Fill, IC), The 
recovery of the ialmunoreitctive material applied to 
HPLC analysis was 90%. The material wlis subjected to 
sequence analysis, It was essentially pure, and the se. 
quenc¢ corresponded to Ihat of somatostatin 14: Ahi. 
Gly. (Cys) - Lys. Ash- Phe. Phe-Trp. Lys .Thr. Phe.Thr- 
Ser.(Cys). The ¢yslcine residues ~¢¢re not ideniified, but 
'holes' in the sequence filled with Cys in position 3 and 
14, 
Pil, ID shows the elution profile of synthetic cyclic 
somiitoslatin, dissolved in acetic acid and subjected to 
gel filtration in acetic acid on a K 16/100 Sephadex GS0 
column The elution pattern was very similar to that of 
extractable pancreatic SL[ (Fig. IA). 
The second half of the material was used for gel 
filtralion analysis on both acetic acid and assay buffer 
columns (Fig, 2A). Again. in acetic acid the SLI eluted 
in a broad double peak with one peak at K= 0.9-0,95 
and another around 1,05 in assay buffer (Fill. 2B) (pH 
7.5) an apparently homogenous peak eluted at K. 1,05. 
To  another sample of the pool mercaptoethanol was 
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Fig. 2. Gel filtration profiles of SLI purified from pancreas extracts 
and subjected to gel filtration analysis in acetic acid (panels A and C) 
and assay buffer at pH ?.5 (panels B and D), without (top panels) or 
with addition of 2°/o mercaptoethanol to the applied sam ple (panel C) 
or to both the sample and the elutian medium (panel D), Effluent con- 
centrations of SLI are plotted against thocoofficients of distributioni 
Kd, 
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added to a concentration of 2% (v/v), and the material 
w~ ehromatogrnphed on both the acetic acid column 
and on the assay burrer column. Mercaptoethanol was 
added to the nssay buffer to a concentration of 2%, As 
shown in Fill. 2C and D, the rnercaptoeflmnol treatment 
¢llanged theelutlon pattern of SLI. The elution position 
of SLI on the stray buffer column now had a K= of 
0.90, and on the acetic acid column Ihe heterogeneity 
disappeared and all of the SLI eiuted as a homogenous 
peak at K~ 0.90. 
4. DISCUSSION 
In order to explain the apparent heterolleneity of im- 
munoreactive somatostafin in pancreatic extracts our 
first approach was to isolate the responsible peptides by 
high pressure liquid chromatography, According to the 
data reported by McMartin and Purdon and by 
Shoelson et al. [ll,12J somatostatin 14 and desAla t- 
somatostattn 14 would be readily separuble by HPLC. 
However, in spite of the fact that the starting material 
clearly contained moieties with different gel filtration 
elution positions and the fact that neglible amounts 
were lost during the HPLC purification~, the SLI 
always elutcd as a single and eventually pure peptide, 
with the sequence of somatostatin 14. 
We then considered the possibility that varying 
degrees of reduction or oxidation of the somatostatin 
molecule could explain the heterogeneity. It w~s found 
that the same material which upon gel filtration in 
acetic acid showed a double peak, elated as a single 
peak when run at a neutral pH in assay buffer. How- 
ever, the elution position at K,, 1.05, i.e.with an elution 
volume exceeding the volume of the total mobile phase 
of the column as determined with 2ZNaCl, clearly in- 
dicated that an interaction between somatostatin and 
the column matrix had taken place, causing the delayed 
elution. This interaction might apply equally to both of 
the peaks whereby the heterogeneity would be ob- 
scured. Another explanation could be that somatostatin 
spontaneously cyclizises at pH 7.4 and that the 
homogenous appearance was due to a predominant 
presence of cyclic somatostatin. The experiments with 
the same column and the same buffer but with addition 
of the reducing agent, mercaptoethanol, showed that 
this explanation could be true. Thus, all of the im- 
munoreactivity now eluted at Ka 0.9 as a slender, ap- 
parently homogenous peak. Similar results were obtain- 
ed with the acetic acid column. After mercaptoethanol 
addition the double peak pattern disappeared and all of 
the SLi eluled at K,j O.9. In further support or this= inter. 
prelaflon, w~ found 1hat synthetic cyclic somatostatin, 
dissolved in acetic acid, also= eluted in a double.peaked 
manner upon gel filiration In acetic #cid, suggesting 
that even the ~ynthetlc material was partly converted to 
reduced, linear somatostatin in acetic acid. 
We conclude from these results that the heterollenelty 
was not, as previously believed [6,10], due to the 
presence of molecular forms with an amino acid com- 
position different from that of somatostatin I4. Rather, 
it was due to the formation of a mixture of oxidized and 
redL~ced somatostatin in acetic acid. By reduction, the 
molecule acquires a linear conformation, whereby its 
hydrodynamic volume increases, causing it to elate 
earlier upon gel filtration. Apparently a mixture of 
reduced and oxidized molecules occur in acetic acid and 
this explains the appearance of SLI at different dution 
positions. 
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